SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Rocky Brands' board declared a quarterly cash dividend of $0.17 per share payable June 15, 2026 to shareholders of record as of June 1, 2026. The anno...
# FDA Approves QUAGEN's ANDA Application, Expanding Generic Drug Portfolio QUAGEN has received FDA approval for ANDA216910, strengthening its positio...
Jerome H. Powell has been named chair pro tempore of the Federal Reserve Board. He will serve in this interim capacity until Kevin M. Warsh is sworn i...
The Federal Reserve Board has approved an application submitted by the Stephen M. Calk 2025 Trust. The specific details and implications of the approv...
The Federal Reserve Board does not object to United Texas Bank of Dallas converting from a Federal Reserve-supervised bank to a national bank supervis...
The Federal Reserve Board has terminated all enforcement actions against UBS Group AG, Credit Suisse AG, and related entities. This action follows UBS...
# FDA Approves Accord BioPharma Biologic; Entry Expected to Intensify Market Competition Accord BioPharma Inc. has received FDA approval for a new bi...
# FDA Approves Jubilant Generics ANDA Application Jubilant Generics received FDA approval for ANDA210329 on May 15, 2026, positioning the company to ...
# FDA Approves Dr. Reddy's Generic Drug Application Dr. Reddy's Laboratories has received FDA approval for ANDA214733, expanding its generic pharmace...
Zydus Lifesciences announced that FDA has granted approval for its generic drug submission referenced by ANDA217758, potentially impacting the market ...
DR REDDYS announced the FDA's approval of its ANDA215820 on May 15, 2026, which is expected to broaden its commercial footprint once the product launc...
Stephen I. Miran has submitted his resignation as a member of the Federal Reserve Board. His resignation will become effective when or shortly before ...
The Federal Reserve Board published findings from two surveys of senior bank financial officers regarding their preferences on discount window operati...
# FDA Approves Amneal Pharmaceuticals' Generic Tretinoin Topical Formulation Amneal Pharmaceuticals NY LLC received FDA approval for its generic tret...
# FDA Approves Renova Pharmaceuticals' Generic L-Glutamine Oral Formulation Renova Pharmaceuticals LLC has received FDA approval for its generic L-gl...
# FDA Approves Chiesi's New Drug Application NDA219622 Chiesi Pharmaceuticals has received FDA approval for a new drug candidate under application ND...
Ionetix Corporation announced the FDA approval of Gallium Ga-68 Gozetotide, a generic version of the prostate cancer imaging agent PSMA-11, which is e...
The Federal Reserve Board published its annual assessment of American household economic conditions for 2025. The report provides data on household fi...
On May 13, 2026, BEONE MEDICINES USA may experience a significant market impact with the likely approval of a new drug, though the specific substance ...
Caplin Steriles Limited has received FDA approval for its ANDA220068 application, granting it authorization to market foscarnet sodium injection in th...